SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-029550
Filing Date
2019-05-15
Accepted
2019-05-15 08:11:13
Documents
4
Period of Report
2019-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-9979_18k.htm 8-K 27759
2 EX-99.1 a19-9979_1ex99d1.htm EX-99.1 19397
3 GRAPHIC g99791mmi001.gif GRAPHIC 4360
4 GRAPHIC g99791mmi002.gif GRAPHIC 8252
  Complete submission text file 0001104659-19-029550.txt   66012
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 19825158
SIC: 2836 Biological Products, (No Diagnostic Substances)